Skip to content
FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC episode artwork

Jul 18, 2025 45 min

FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC

from Lung Cancer Considered Hosted by IASLC

FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC by IASLC

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC

0:00 45:33

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Lung Cancer Considered?

This episode is 45 minutes long.

When was this Lung Cancer Considered episode published?

This episode was published on July 18, 2025.

Can I download this Lung Cancer Considered episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.